Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309

Blood

Volumn 98, Issue 4, 2001, Pages 1150-1159

  Ruckes, Tobias ^a,b,c   Saul, Domenica ^a,b,c   Van Snick, Jacques ^a,b,c   Hermine, Olivier ^a,b,c   Grassmann, Ralph ^a,b,c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE I 309; CHEMOKINE RECEPTOR CCR8; HELIX LOOP HELIX PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; TAX PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DEC 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL; LEUKEMOGENESIS; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

EID: 0035883074     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.4.1150     Document Type: Article

References (89)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415-7419.
2. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A. 1983;80:3618-3622.
3. Blattner WA. Human retroviruses: their role in cancer. Proc Assoc Am Physicians. 1999;111:563-572.
4. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med. 2000;18:109-119.
5. Grassmann R, Fleckenstein B, Desrosiers RC. Viral transformation of human T lymphocytes. Adv Cancer Res. 1994;63:211-244.
6. Maruyama K, Fukushima T, Kawamura K, Mochizuki S. Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I. Cancer Res. 1990;50:5697S-5702S.
7. Kamada N, Sakurai M, Miyamoto K, et al. Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report. Cancer Res. 1992;52:1481-1493.
8. Miyake H, Suzuki T, Hirai H, Yoshida M. Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. Virology. 1999;253:155-161.
9. Cavrois M, Leclercq I, Gout O, Gessain A, WainHobson S, Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene. 1998;17:77-82.
10. Gessain A. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection. J Neurovirol. 1996;2:299-306.
11. Izumo S, Umehara F, Osame M. HTLV-I-associated myelopathy. Neuropathology. 2000;20(suppl):S65-S68.
12. Jeffery KJ, Usuku K, Hall SE, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A. 1999;96:3848-3853.
13. Hidaka M, Inoue J, Yoshida M, Seiki M. Post-transcriptional regulator (Rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 1988;7:519-523.
14. Grone M, Koch C, Grassmann R. The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation. Virology. 1996;218:316-325.
15. Ciminale V, D'Agostino DM, Zotti L, Chieco-Bianchi L. Coding potential of the X region of human T-cell leukemia/lymphotropic virus type II. J AIDS Hum Retrovirol. 1996;13(suppl 1):S220-S227.
16. Van Orden K, Yan JP, Ulloa A, Nyborg JK. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene. 1999;18:3766-3772.
17. Lenzmeier BA, Baird EE, Dervan PB, Nyborg JK. The tax protein-DNA interaction is essential for HTLV-I transactivation in vitro. J Mol Biol. 1999;291:731-744.
18. Tang Y, Tie F, Boros I, Harrod R, Glover M, Giam CZ. An extended alpha-helix and specific amino acid residues opposite the DNA-binding surface of the cAMP response element binding protein basic domain are important for human T cell lymphotropic retrovirus type I Tax binding. J Biol Chem. 1998;273:27339-27346.
19. Mesnard JM, Devaux C. Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein. Virology. 1999;257:277-284.
20. Grassmann R, Berchtold S, Radant I, et al. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol. 1992;66:4570-4575.
21. Akagi T, Shimotohno K. Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J Virol. 1993;67:1211-1217.
22. Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1995;92:1057-1061.
23. Hollsberg P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev. 1999;63:308-333.
24. Schmitt I, Rosin O, Rohwer P, Gossen M, Grassmann R. Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol. 1998;72:633-640.
25. Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 1998;93:81-91.
26. Neuveut C, Jeang KT. HTLV-I Tax and cell cycle progression. Prog Cell Cycle Res. 2000;4:157-162.
27. Suzuki T, Narita T, Uchida-Toita M, Yoshida M. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms. Virology. 1999;259:384-391.
28. Haller K, Ruckes T, Schmitt I, Saul D, Derow E, Grassmann R. Tax-dependent stimulation of G1 phase-specific cyclin-dependent kinases and increased expression of signal transduction genes characterize HTLV type 1-transformed T cells. AIDS Res Hum Retroviruses. 2000;16:1683-1688.
29. Mulloy JC, Kislyakova T, Cereseto A, et al. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol. 1998;72:8852-8860.
30. Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol. 1998;72:1165-1170.
31. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7:812-821.
32. van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 1993;262:2050-2054.
33. Kao SY, Marriott SJ. Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J Virol. 1999;73:4299-4304.
34. Fujii M, Sassone-Corsi P, Verma IM. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1988;85:8526-8530.
35. Niewiesk S, Daenke S, Parker CE, et al. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol. 1995;69:2649-2653.
36. Marriott SJ, Trinh D, Brady JN. Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: a potential role in HTLV-I pathogenesis. Oncogene. 1992;7:1749-1755.
37. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 1986;5:2883-2888.
38. Cross SL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F, Leonard WJ. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell. 1987;49:47-56.
39. Yoshida M, Suzuki T, Fujisawa J, Hirai H. HTLV-1 oncoprotein Tax and cellular transcription factors. Curr Top Microbiol Immunol. 1995;193:79.
40. Baba M, Imai T, Yoshida T, Yoshie O. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: role of the viral transactivator Tax. Int J Cancer. 1996;66:124-129.
41. Santiago F, Clark E, Chong S, et al. Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol. 1999;73:9917-9927.
42. Akagi T, Ono H, Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene. 1996;12:1645-1652.
43. Cereseto A, Diella F, Mulloy JC, et al. p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood. 1996;88:1551-1560.
44. Jeang KT, Widen SG, Semmes OJ, Wilson SH. HTLV-I trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene. Science. 1990;247:1082-1084.
45. Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. Virology. 1997;231:135-140.
46. Harhaj EW, Good L, Xiao G, Sun SC. Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene. 1999;18:1341-1349.
47. Bex F, Gaynor RB. Regulation of gene expression by HTLV-I Tax protein. Methods. 1998;16:83-94.
48. Diatchenko L, Lau YF, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996;93:6025-6030.
49. Rosin O, Koch C, Schmitt I, Semmes OJ, Jeang KT, Grassmann R. A human T-cell leukemia virus Tax variant incapable of activating NF-kappaB retains its immortalizing potential for primary Tlymphocytes. J Biol Chem. 1998;273:6698-6703.
50. Van Snick J, Houssiau F, Proost P, Van Damme J, Renauld JC. I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J Immunol. 1996;157:2570-2576.
51. Derfuss T, Fickenscher H, Kraft MS, et al. Anti-apoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: stabilization of mitochondria and inhibition of caspase-3-like activity. J Virol. 1998;72:5897-5904.
52. Maluish AE, Strong DM. Lymphocyte proliferation. In Rose NR, de Macario EC, Folds JD, Lane HC, Nakamura RM (eds). Manual of Clinical Immunology. Washington, DC: American Society for Microbiology; 1986:274-281.
53. Matteucci C, Grelli S, De Smaele E, Fontana C, Mastino A. Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry. Cytometry. 1999;35:145-153.
54. Shirono K, Hattori T, Hata H, Nishimura H, Takatsuki K. Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia. Blood. 1989;73:1664-1671.
55. Shimamura R, Kudo J, Kondo H, et al. Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells. Blood. 1990;76:977-984.
56. Shen M, Kawamoto T, Yan W, et al. Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem Biophys Res Commun. 1997;236:294-298.
57. Wolf FW, Sarma V, Seldin M, et al. B94, a primary response gene inducible by tumor necrosis factor-alpha, is expressed in developing hematopoietic tissues and the sperm acrosome. J Biol Chem. 1994;269:3633-3640.
58. Yi H, Morton CC, Weremowicz S, McBride OW, Kelly K. Genomic organization and chromosomal localization of the DUSP2 gene, encoding a MAP kinase phosphatase, to human 2p11.2-q11. Genomics. 1995;28:92-96.
59. Blomstrom DC, Fahey D, Kutny R, Korant BD, Knight E Jr. Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem. 1986;261:8811-8816.
60. Cosenza SC, Carter R, Pena A, et al. Growth-associated gene expression is not constant in cells traversing G-1 after exiting mitosis. J Cell Physiol. 1991;147:231-241.
61. Thomson AM, Rogers JT, Leedman PJ. Iron-regulatory proteins, iron-responsive elements and territin mRNA translation. Int J Biochem Cell Biol. 1999;31:1139-1152.
62. Miller MD, Hata S, De Waal MR, Krangel MS. A novel polypeptide secreted by activated human T lymphocytes. J Immunol. 1989;143:2907-2916.
63. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995;23:4878-4884.
64. Itoh N, Yonehara S, Ishii A, et al. The potypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233-243.
65. Debatin KM, Goldman CK, Waldmann TA, Krammer PH. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood. 1993;81:2972-2977.
66. Yamada Y, Sugahara K, Tsuruda K, et al. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production. Cancer Lett. 1999;147:215-219.
67. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415-1420.
68. Wheat WH, Roesler WJ, Klemm DJ. Simian virus 40 small tumor antigen inhibits dephosphorylation of protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol. 1994;14:5881-5890.
69. Sarma V, Wolf FW, Marks RM, Shows TB, Dixit VM. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J Immunol. 1992;148:3302-3312.
70. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E Jr, Borden E. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol. 1996;157:4100-4108.
71. Yamada Y, Ohmoto Y, Hata T, et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma. 1996;21:443-447.
72. Selvan RS, Zhou LJ, Krangel MS. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol. 1997;27:687-694.
73. Mori N, Shirakawa F, Saito K, Murakami S, Oda S, Eto S. Transactivation of the interleukin-1 alpha gene promoter by human T-cell leukemia virus type I tax in T cells [letter]. Blood. 1994;84:1688.
74. Oh CK, Metcalfe DD. Transcriptional regulation of the TCA3 gene in mast cells after Fc epsilon RI cross-linking. J Immunol. 1994;153:325-332.
75. Burd PR, Freeman GJ, Wilson SD, et al. Cloning and characterization of a novel T cell activation gene. J Immunol. 1987;139:3126-3131.
76. Keizer DW, Crump MP, Lee TW, Slupsky CM, Clark-Lewis I, Sykes BD. Human CC chemokine I-309, structural consequences of the additional disulfide bond. Biochemistry. 2000;39:6053-6059.
77. Napolitano M, Zingoni A, Bernardini G, et al. Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. J Immunol. 1996;157:2759-2763.
78. Roos RS, Loetscher M, Legler DF, Clark-Lewis I, Baggiolini M, Moser B. Identification of CCR8, the receptor for the human CC chemokine I-309. J Biol Chem. 1997;272:17251-17254.
79. Tiffany HL, Lautens LL, Gao JL, et al. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J Exp Med. 1997;186:165-170.
80. Goya I, Gutierrez J, Varona R, Kremer L, Zaballos A, Marquez G. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3. J Immunol. 1998;160:1975-1981.
81. Dairaghi DJ, Fan RA, McMaster BE, Hanley MR, Schall TJ. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem. 1999;274:21569-21574.
82. Luttichau HR, Stine J, Boesen TP, et al. A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus Molluscum contagiosum. J Exp Med. 2000;191:171-180.
83. Napolitano M, Santoni A. Structure and function of the CC chemokine receptor (CCR) 8. Forum (Genova). 1999;9:315-324.
84. Dunbar CE, Browder TM, Abrams JS, Nienhuis AW. COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science. 1989;245:1493-1496.
85. Browder TM, Dunbar CE, Nienhuis AW. Private and public autocrine loops in neoplastic cells. Cancer Cells. 1989;1:9-17.
86. Harsh GR, Keating MT, Escobedo JA, Williams LT. Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neurooncol. 1990;8:1-12.
87. Mitjavila MT, Le Couedic JP, Casadevall N, et al. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro. J Clin Invest. 1991;88:789-797.
88. Nicol C, Mahieux R, Takemoto S, Franchini G. Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood. 2000;96:275-281.
89. Tsukahara T, Kannagi M, Ohashi T, et al. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol. 1999;73:7981-7987.